Last reviewed · How we verify

Intravenous Lidocaine infusion + Standard Anesthesia

Instituto Mexicano del Seguro Social · FDA-approved active Small molecule

Intravenous Lidocaine infusion + Standard Anesthesia is a Local anesthetic (sodium channel blocker) Small molecule drug developed by Instituto Mexicano del Seguro Social. It is currently FDA-approved for Adjunctive analgesia during general anesthesia and surgery, Postoperative pain reduction. Also known as: Xylocaine®, Lignocaine.

Intravenous lidocaine blocks sodium channels in nerve fibers to provide local anesthesia and analgesia, used as an adjunct to standard general anesthesia.

Intravenous lidocaine blocks sodium channels in nerve fibers to provide local anesthesia and analgesia, used as an adjunct to standard general anesthesia. Used for Adjunctive analgesia during general anesthesia and surgery, Postoperative pain reduction.

At a glance

Generic nameIntravenous Lidocaine infusion + Standard Anesthesia
Also known asXylocaine®, Lignocaine
SponsorInstituto Mexicano del Seguro Social
Drug classLocal anesthetic (sodium channel blocker)
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia and Perioperative Pain Management
PhaseFDA-approved

Mechanism of action

Lidocaine is a local anesthetic that inhibits sodium influx into nerve cells, preventing depolarization and conduction of action potentials. When administered intravenously during anesthesia, it enhances analgesia, reduces anesthetic requirements, and may decrease postoperative pain and opioid consumption. This combination approach leverages lidocaine's analgesic properties alongside conventional anesthetic agents.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Intravenous Lidocaine infusion + Standard Anesthesia

What is Intravenous Lidocaine infusion + Standard Anesthesia?

Intravenous Lidocaine infusion + Standard Anesthesia is a Local anesthetic (sodium channel blocker) drug developed by Instituto Mexicano del Seguro Social, indicated for Adjunctive analgesia during general anesthesia and surgery, Postoperative pain reduction.

How does Intravenous Lidocaine infusion + Standard Anesthesia work?

Intravenous lidocaine blocks sodium channels in nerve fibers to provide local anesthesia and analgesia, used as an adjunct to standard general anesthesia.

What is Intravenous Lidocaine infusion + Standard Anesthesia used for?

Intravenous Lidocaine infusion + Standard Anesthesia is indicated for Adjunctive analgesia during general anesthesia and surgery, Postoperative pain reduction.

Who makes Intravenous Lidocaine infusion + Standard Anesthesia?

Intravenous Lidocaine infusion + Standard Anesthesia is developed and marketed by Instituto Mexicano del Seguro Social (see full Instituto Mexicano del Seguro Social pipeline at /company/instituto-mexicano-del-seguro-social).

Is Intravenous Lidocaine infusion + Standard Anesthesia also known as anything else?

Intravenous Lidocaine infusion + Standard Anesthesia is also known as Xylocaine®, Lignocaine.

What drug class is Intravenous Lidocaine infusion + Standard Anesthesia in?

Intravenous Lidocaine infusion + Standard Anesthesia belongs to the Local anesthetic (sodium channel blocker) class. See all Local anesthetic (sodium channel blocker) drugs at /class/local-anesthetic-sodium-channel-blocker.

What development phase is Intravenous Lidocaine infusion + Standard Anesthesia in?

Intravenous Lidocaine infusion + Standard Anesthesia is FDA-approved (marketed).

What are the side effects of Intravenous Lidocaine infusion + Standard Anesthesia?

Common side effects of Intravenous Lidocaine infusion + Standard Anesthesia include Hypotension, Bradycardia, Dizziness, Tinnitus, Perioral numbness, Seizures (at high doses).

What does Intravenous Lidocaine infusion + Standard Anesthesia target?

Intravenous Lidocaine infusion + Standard Anesthesia targets Voltage-gated sodium channels and is a Local anesthetic (sodium channel blocker).

Related